CB2 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CB2 Antibodies for various research applications. Monoclonal CB2 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CB2, a member of the cannabinoid receptor family, plays a crucial role in the endocannabinoid system, influencing various physiological processes including immune response and pain modulation. The significance of CB2 in neuroprotection and inflammation has made it a key target in numerous studies related to pain management and neurodegenerative diseases. Researchers worldwide utilize CB2 monoclonal antibodies to advance understanding of cellular signaling pathways and molecular mechanisms. Advanced detection methods, including fluorescein isothiocyanate (FITC), phycoerythrin (PE), and horseradish peroxidase (HRP) conjugates, enable precise visualization and quantification of CB2 expression patterns. Current investigations focus on CB2's potential therapeutic applications in inflammatory conditions and neurological disorders. Santa Cruz Biotechnology monoclonal antibodies support the scientific community's efforts to unlock new therapeutic strategies through detailed CB2 research.